Shanghai Serum Bio-Technology Co., Ltd. engages in the research, development, production, and sell preventive and therapeutic drugs for biotoxins and biosafety. Its key products include equine anti-tetanus immune globulin, venin series, and rabies serum. The company was founded by Ai Xian Zhao on November 9, 1999 and is headquartered in Shanghai, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company